We hypothesize that also the positive prognostic impact of PD-1+ and PD-L1+ TILs is based on regulatory and not yet completely elucidated mechanisms within the immune network in the tumor microenvironment as outlined above. This evidence concerns the gene PDCD1 and neoplasm.